The Hematology Podcast
In The Hematology Podcast, we dig into the clinical, the theoretical, and the practical, as we discuss the past, present, and future of the hematological field. MAT-DK-2100201(1.0) March 2021
Episodes
21 episodes
TMA or Thrombotic microangiopathy - from Symptoms to Treatment
In this episode of The Hematology Podcast, we will delve into the complex world of thrombotic microangiopathy, or TMA. This condition encompasses a group of disorders characterized by small blood clots forming in the smallest blood vessels, lea...
•
Season 4
•
Episode 20
•
35:23
Decoding Multiple Myeloma genetic profile: The Power of Liquid Biopsy-Derived DNA
In this episode, we dive into the fascinating world of liquid biopsy-derived DNA as a revolutionary tool for comprehensive mutation profiling in multiple myeloma. This innovative approach offers a non-invasive way to analyse genetic alterations...
•
Season 4
•
Episode 19
•
21:09
Transfusion Dependent Thalassemia - the Severe Spectrum
In this episode, we focus on a severe form of Thalassemia known as Thalassemia major. In a previous episode, we discussed Thalassemia minor and intermedia with Professor Dr. Bart Biemond from Amsterdam UMC. Today, we’ll delve deeper into the ch...
•
Season 4
•
Episode 18
•
44:26
AML - from basics to future prospectives
Acute myeloid leukemia (AML) is a hematopoietic stem cell-derived myeloid malignancy characterized by manifold genetic aberrations and poor overall survival. Standard treatment for newly diagnosed fit AML patients is intensive chemotherapy. Rel...
•
Season 4
•
Episode 17
•
30:50
Smoldering Multiple Myeloma – to treat or not to treat?
Smoldering multiple myeloma (SMM) is an intermediate condition that lies between Monoclonal gammopathy of undetermined significance (MGUS) and active multiple myeloma along the spectrum of clonal plasma cell proliferative disorders. Smoldering ...
•
Season 4
•
Episode 16
•
26:05
Thalassemia - a blind spot
Thalassemia is a hereditary blood disorder, in which the synthesis of hemoglobin chains is impaired. Consequently, people with thalassemia minor may have slight to severe anemia which usually does not cause any problems. Thalassemia major...
•
Season 4
•
Episode 15
•
40:32
Causes, symptoms and diagnosing ASMD – A rare lysosomal storage disorder
Today we will discuss a rare, inherited metabolic disorder known as ASMD, acid sphingomyelinase deficiency (or historically known as Niemann-Pick types A, A/B, and B). This genetic condition is very rare. It can be diagnosed, after suspicion, b...
•
Season 3
•
Episode 14
•
38:17
MGRS- Monoclonal Gammopathy of Renal Significance
Monoclonal gammopathy of renal significance (MGRS) is a hemato-nephrological term referring to a heterogeneous group of kidney disorders characterized by direct or indirect kidney injury caused by a monoclonal immunoglobulin (MIg) produced by a...
•
Season 3
•
Episode 13
•
25:40
Sickle cell disease - A hereditary blood disorder
Sickle cell disease (SCD) is a hereditary blood disorder, where red blood cells have the shape of a C or sickle - hence the name. Sickle cells have a shorter lifespan than normal red blood cells, which causes anemia. Additionally, sickle cells ...
•
Season 3
•
Episode 12
•
1:02:36
Extramedullary disease in Multiple Myeloma
Extramedullary disease (EMD) represents an aggressive form of multiple myeloma, characterized by the ability of myeloma cells to form tumors outside the bone marrow independently. Scientific research is continuously evolving, leading to d...
•
Season 3
•
Episode 11
•
22:39
Recent findings in MGUS
Monoclonal gammopathy of undetermined significance, called MGUS, is a blood condition which indicates occurrence of clonal cells that secrete monoclonal immunoglobulins. MGUS as such, is not a harmful disease, and usually doesn’t require treatm...
•
Season 3
•
Episode 10
•
44:10
Waldenström Macroglobulinemia: a clinical update
Waldenström Macroglobulinemia is a rare type of non-Hodgkin lymphoma affecting B-cells. Waldenström Macroglobulinemia is characterised by high levels of circulating antibodies, immunoglobulin M, which is made and secreted by the cells involved ...
•
Season 3
•
Episode 9
•
43:03
Mental health during and after cancer treatment
Mental health includes our emotional, psychological and social well-being. A physical illness can have a severe impact on mental health. As health care professionals we often focus primarily on treatment and how to handle side effects and compl...
•
Season 2
•
Episode 8
•
40:20
Challenges in diagnosing Gaucher and other rare inherited metabolic disorders
In this episode we will discuss rare, inherited metabolic disorders in general, as well diseases such as Gaucher and other diseases. These genetic conditions are very rare. They can be diagnosed, after suspicion, by different screening test. Bu...
•
Season 2
•
Episode 7
•
37:06
Hemoglobinopathies
Hemoglobinopathies have previously been rare in the Nordic population but with increasing migration we now meet many patients with different types of thalassemias and hemoglobin variants. It is important to recognize these conditions and diagno...
•
Season 2
•
Episode 6
•
36:29
MRD as primary endpoint
Minimal residual disease (MRD) can today be evaluated in individual patient after treatment using various methods with high sensitivity. MRD indicates remaining malignant cells that could be a source of relapse of the disease. Could MRD also be...
•
Season 1
•
Episode 5
•
40:00
Minimal Residual Disease (MRD) - Cost vs Benefit
Detection of Minimal Residual Disease (MRD) is becoming more important in different fields of hematology including Multiple Myeloma. Over the past decades we’ve been able to improve the sensitivity of detecting minimal levels of MRD throu...
•
Season 1
•
Episode 4
•
27:39
AI - The future of pathology?
One drop of blood, two sheets of glass, 40x objective. Hematological diagnostics demands a keen eye and sound reasoning. At the same time, artificial intelligence is entering the field in a big way. We ask: are the days of Giemsa coloring past ...
•
Season 1
•
Episode 3
•
26:06
It’s in the Genes
We’re currently able to scan the entire human genome in a single day, and the application of genetic sequencing has the potential to improve diagnosis, prognosis and treatment. Ahead lies the opportunity to easily discover rare hematological di...
•
Season 1
•
Episode 2
•
31:58